ANGIODYNAMICS, INC.

🇭🇰Hong Kong, China

Country: 🇭🇰Hong Kong, China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Evaluating the Efficacy, Safety and Long Term Functional Outcomes of Percutaneous Mechanical Aspiration Thrombectomy for Treatment of Acute Pulmonary Embolism Using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System

Not Applicable

Not yet recruiting

Conditions: Acute Pulmonary Embolism (PE)
Pulmonary Embolism

First Posted Date: 2024-11-20

Last Posted Date: 2024-11-20

Lead Sponsor: Angiodynamics, Inc.

Target Recruit Count: 366

Registration Number: NCT06697314

Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism

Not Applicable

Completed

Conditions: Pulmonary Embolism
Acute Pulmonary Embolism

Interventions: Device: AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE

First Posted Date: 2022-04-08

Last Posted Date: 2024-07-19

Lead Sponsor: Angiodynamics, Inc.

Target Recruit Count: 122

Registration Number: NCT05318092

Locations: 🇺🇸
UCLA Health, Los Angeles, California, United States
🇺🇸
Emory University at Grady Memorial Hospital, Atlanta, Georgia, United States
🇺🇸
Ohio State University Wexner Medical Center, Columbus, Ohio, United States

and more 22 locations

Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue

Not Applicable

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Device: Irreversible Electroporation

First Posted Date: 2021-07-22

Last Posted Date: 2023-08-04

Lead Sponsor: Angiodynamics, Inc.

Target Recruit Count: 121

Registration Number: NCT04972097

Locations: 🇺🇸
Northwell Health, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Weill Cornell Medicine, New York, New York, United States

and more 14 locations

Post-Market Registry of AURYON™ Atherectomy Device in Subjects Affected With Infrainguinal Peripheral Artery Disease

Active, not recruiting

Conditions: Infrainguinal Peripheral Artery Disease
PAD
Peripheral Arterial Disease

Interventions: Device: AURYON™ System

First Posted Date: 2020-01-18

Last Posted Date: 2023-02-21

Lead Sponsor: Angiodynamics, Inc.

Target Recruit Count: 104

Registration Number: NCT04229563

Locations: 🇺🇸
Pulse Cardiovacular, Scottsdale, Arizona, United States
🇺🇸
Comprehensive Cardiovascular, Davenport, Florida, United States
🇺🇸
Hurricane Cardiology, New Braunfels, Texas, United States

and more 2 locations

A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer

Active, not recruiting

Conditions: Stage III Pancreatic Cancer

Interventions: Drug: SOC
Device: NanoKnife System

First Posted Date: 2019-04-02

Last Posted Date: 2024-01-31

Lead Sponsor: Angiodynamics, Inc.

Target Recruit Count: 532

Registration Number: NCT03899649

Locations: 🇺🇸
Presbyterian Hospital, Columbia, New York, New York, United States
🇺🇸
Moores Cancer Center, UC San Diego Health, La Jolla, California, United States
🇺🇸
Barnes-Jewish Hospital, Saint Louis, Missouri, United States

and more 11 locations

A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer

Phase 3

Recruiting

Conditions: Stage III Pancreatic Cancer

Interventions: Drug: Modified FOLFIRINOX Regimen
Device: NanoKnife System

First Posted Date: 2019-04-02

Last Posted Date: 2022-11-25

Lead Sponsor: Angiodynamics, Inc.

Target Recruit Count: 528

Registration Number: NCT03899636

Locations: 🇺🇸
University of South Florida/Tampa, Tampa, Florida, United States
🇺🇸
Northwest Community Healthcare, Arlington Heights, Illinois, United States
🇺🇸
St. Luke's Cancer Center, Easton, Pennsylvania, United States

and more 3 locations

Initial Experience With the AngioVac Venous Drainage Cannula

Completed

Conditions: Heart Disease

First Posted Date: 2016-05-17

Last Posted Date: 2017-12-08

Lead Sponsor: Angiodynamics, Inc.

Target Recruit Count: 51

Registration Number: NCT02775565

Locations: 🇺🇸
Providence St. Joseph, Burbank, California, United States
🇺🇸
MUSC, Charleston, South Carolina, United States
🇺🇸
UCLA, Los Angeles, California, United States

and more 2 locations

SeCure Endovenous Laser Treatment Study

Not Applicable

Completed

Conditions: Chronic Venous Insufficiency

Interventions: Device: VenaCure EVLT 400 µm fiber Procedure Kit

First Posted Date: 2014-08-13

Last Posted Date: 2020-05-19

Lead Sponsor: Angiodynamics, Inc.

Target Recruit Count: 112

Registration Number: NCT02215369

Locations: 🇺🇸
Midwest Institute for Minimally Invasive Therapies, Melrose Park, Illinois, United States
🇺🇸
The Vein Center of Virginia, Norfolk, Virginia, United States
🇺🇸
Vein Clinics of America, Orland Park, Illinois, United States

and more 4 locations

Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk Patients

Not Applicable

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Device: NanoKnife Procedure

First Posted Date: 2013-10-31

Last Posted Date: 2023-02-01

Lead Sponsor: Angiodynamics, Inc.

Target Recruit Count: 6

Registration Number: NCT01972867

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸
Rush University Medical Center, Chicago, Illinois, United States

The PROOF Study: The PICC Related Obstruction Of Flow Study

Not Applicable

Terminated

Conditions: Patients Indicated for a PICC for Any Medical Condition

Interventions: Device: Bard® Dual-Lumen PowerPICC SOLO2®
Device: BioFlo™ Peripherally Inserted Central Catheter (PICC)

First Posted Date: 2013-08-13

Last Posted Date: 2019-05-17

Lead Sponsor: Angiodynamics, Inc.

Target Recruit Count: 57

Registration Number: NCT01921114

Locations: 🇨🇭
Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland
🇨🇦
Ottawa Hospital, Ottawa, Ontario, Canada
🇺🇸
University of Miami Hospital, Miami, Florida, United States

and more 2 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy